Marshall Wace, LLP Elevance Health, Inc. Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$497.49 - $547.8 $32.8 Million - $36.2 Million	66,000 New	66,000 $35.8 Million
Q4 2023 Feb 14, 2024	SELL	$433.51 - $488.06 $141 Million - $159 Million	-325,350 Reduced 71.53%	129,483 $61.1 Million
Q3 2023 Nov 14, 2023	SELL	$414.13 - $475.93 $32.4 Million - $37.2 Million	-78,262 Reduced 14.68%	454,833 $198 Million
Q2 2023 Aug 14, 2023	SELL	$436.33 - $496.2 $5.48 Million - $6.24 Million	-12,570 Reduced 2.3%	533,095 $237 Million
Q1 2023 May 15, 2023	BUY	$446.3 - $502.2 $79.9 Million - $89.9 Million	179,016 Added 48.82%	545,665 $251 Million
Q4 2022 Feb 14, 2023	BUY	$465.23 - $546.77 $171 Million - $200 Million	366,649 New	366,649 $188 Million
Q1 2022 May 16, 2022	SELL	$428.44 - $502.48 $209 Million - $245 Million	-486,857 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$370.08 - $467.67 $157 Million - $199 Million	425,351 Added 691.56%	486,857 $226 Million
Q3 2021 Nov 15, 2021	SELL	$357.51 - $398.13 $2.2 Million - $2.45 Million	-6,146 Reduced 9.08%	61,506 $22.9 Million
Q2 2021 Aug 13, 2021	SELL	$352.19 - $401.9 $43.5 Million - $49.6 Million	-123,385 Reduced 64.59%	67,652 $25.8 Million
Q1 2021 May 17, 2021	SELL	$287.7 - $371.31 $13.4 Million - $17.3 Million	-46,655 Reduced 19.63%	191,037 $68.6 Million
Q4 2020 Feb 16, 2021	BUY	$270.17 - $333.15 $16.9 Million - $20.8 Million	62,478 Added 35.66%	237,692 $76.3 Million
Q3 2020 Nov 16, 2020	BUY	$245.73 - $284.63 $29.3 Million - $33.9 Million	119,255 Added 213.11%	175,214 $47.1 Million
Q2 2020 Aug 13, 2020	SELL	$203.3 - $300.59 $5.76 Million - $8.51 Million	-28,312 Reduced 33.6%	55,959 $14.7 Million
Q1 2020 May 15, 2020	SELL	$174.68 - $307.74 $10.3 Million - $18.2 Million	-59,188 Reduced 41.26%	84,271 $19.1 Million
Q4 2019 Feb 14, 2020	BUY	$234.82 - $306.42 $22 Million - $28.7 Million	93,596 Added 187.71%	143,459 $43.3 Million
Q3 2019 Nov 14, 2019	BUY	$237.69 - $310.48 $11.4 Million - $14.9 Million	48,036 Added 2629.23%	49,863 $12 Million
Q2 2019 Aug 14, 2019	SELL	$236.25 - $293.76 $9.76 Million - $12.1 Million	-41,301 Reduced 95.76%	1,827 $515,000
Q1 2019 May 14, 2019	SELL	$248.42 - $317.42 $7.07 Million - $9.04 Million	-28,468 Reduced 39.76%	43,128 $12.4 Million
Q4 2018 Feb 14, 2019	BUY	$249.0 - $296.25 $15.5 Million - $18.5 Million	62,393 Added 677.96%	71,596 $18.8 Million
Q3 2018 Nov 14, 2018	SELL	$238.27 - $274.12 $16.2 Million - $18.7 Million	-68,112 Reduced 88.1%	9,203 $2.52 Million
Q2 2018 Aug 14, 2018	BUY	$220.13 - $245.16 $17 Million - $19 Million	77,315 New	77,315 $18.4 Million

Others Institutions Holding ELV

# of Institutions

1,861

Shares Held

198M

Call Options Held

1.03M

Put Options Held

1.24M

Vanguard Group Inc Valley Forge, PA

21.3M
Shares

$8.62 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

20.7M
Shares

$8.36 Billion
0.26% of portfolio
State Street Corp Boston, MA

10.7M
Shares

$4.32 Billion
0.23% of portfolio
Price T Rowe Associates Inc Baltimore, MD

10.2M
Shares

$4.1 Billion
0.61% of portfolio
Geode Capital Management, LLC Boston, MA

4.85M
Shares

$1.96 Billion
0.21% of portfolio

View Full List

About Elevance Health, Inc.

Ticker ELV
Exchange NYSE
Sector Healthcare
Industry Healthcare Plans
Shares Outstandng 240,000,992
Market Cap $96.9B
Description
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....

More about ELV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account